Veracyte (VCYT) Asset Writedowns and Impairment (2012 - 2025)

Veracyte has disclosed Asset Writedowns and Impairment across 10 years of filings, most recently posting -$5000.0 for Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at -$5000.0, down 100.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.5 million (up 508.52% YoY), and the FY2025 annual result was $20.5 million, up 508.67% from the prior year.
• Asset Writedowns and Impairment came in at -$5000.0 for Q4 2025 at Veracyte, down from $20.5 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $34.9 million in Q3 2023 to a low of -$5000.0 in Q4 2025.
• The 4-year median for Asset Writedowns and Impairment is $2.8 million (2024), against an average of $10.6 million.
• Across the five-year window, Asset Writedowns and Impairment plunged 69.57% in 2024 and plunged 100.18% in 2025, its largest moves.
• Veracyte's Asset Writedowns and Impairment stood at $3.3 million in 2022, then soared by 865.61% to $32.0 million in 2023, then sank by 91.4% to $2.8 million in 2024, then slumped by 100.18% to -$5000.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at -$5000.0 (Q4 2025), $20.5 million (Q2 2025), and $2.8 million (Q4 2024), per Business Quant data.